Form 4 for BIVI BIOVIE INC.

Accepted 2022-08-16 00:00:00 ET · period of report 2022-08-15 · accession 0001520138-22-000362 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2022-08-16	2022-08-15	BIVI	PEIZER TERREN S	Dir, 10%	A - Grant	$1.65	+3.64M	23.17M	+19%	+$6.00M
DI	2022-08-16	2022-08-15	BIVI	PEIZER TERREN S	Dir, 10%	A - Grant	—	+7.27M	7.27M	New	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-08-15	A	A	3,636,364	$1.65	23,166,210	I By Acuitas	—	—	(F2) Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.
2	Derivative	Warrants (right to buy)	2022-08-15	A	A	7,272,728	—	7,272,728	I By Acuitas	$1.82 · 2022-08-15 to 2027-08-15	7,272,728 Common Stock	(F1) On July 15, 2022, BioVie Inc. (the "Issuer") entered into a securities purchase agreement with Acuitas, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $6,000,000.60, (i) 3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022. (F2) Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.